Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
19,523,924
-
Share change
-
+6,615,567
-
Total reported value
-
$1,824,936,990
-
Put/Call ratio
-
214%
-
Price per share
-
$93.26
-
Number of holders
-
401
-
Value change
-
+$621,552,740
-
Number of buys
-
285
-
Number of sells
-
56
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2020
As of 31 Dec 2020,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
401 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,523,924 shares.
The largest 10 holders included
MORGAN STANLEY, UBS Group AG, BANK OF AMERICA CORP /DE/, LPL Financial LLC, JANE STREET GROUP, LLC, COMMONWEALTH EQUITY SERVICES, LLC, WELLS FARGO & COMPANY/MN, ADVISOR GROUP HOLDINGS, INC., MAINSTAY CAPITAL MANAGEMENT LLC /ADV, and Claraphi Advisory Network, LLC.
This page lists
406
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.